CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Assets | ₹32,130 Cr | ₹29,007 Cr | ₹26,652 Cr | ₹24,837 Cr | ₹23,423 Cr |
What is the latest Total Assets ratio of CIPLA ?
Year | Total Assets |
---|---|
Mar2024 | ₹32,130 Cr |
Mar2023 | ₹29,007 Cr |
Mar2022 | ₹26,652 Cr |
Mar2021 | ₹24,837 Cr |
Mar2020 | ₹23,423 Cr |
How is Total Assets of CIPLA Trending?
Years | Total Assets | % Change | |
---|---|---|---|
Mar2024 | ₹32,130 Cr | 10.77 | |
Mar2023 | ₹29,007 Cr | 8.83 | |
Mar2022 | ₹26,652 Cr | 7.31 | |
Mar2021 | ₹24,837 Cr | 6.04 | |
Mar2020 | ₹23,423 Cr | - |
Compare Total Assets of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹122,015.2 Cr | 2.6% | -0.1% | 0.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,068.0 Cr | 1.4% | 0.1% | 13.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,105.0 Cr | 0.8% | 12.3% | 47.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,651.0 Cr | 7.8% | 12.9% | 13.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,942.0 Cr | 2.7% | -0.6% | 14.4% | Stock Analytics | |
MANKIND PHARMA | ₹98,130.4 Cr | 1.3% | -4.8% | 9.3% | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 2.6% |
-0.1% |
0.6% |
SENSEX | 2.1% |
3.7% |
14.3% |
You may also like the below Video Courses